2019
DOI: 10.7150/thno.33100
|View full text |Cite
|
Sign up to set email alerts
|

Endocytosis-mediated mitochondrial transplantation: Transferring normal human astrocytic mitochondria into glioma cells rescues aerobic respiration and enhances radiosensitivity

Abstract: Emerging evidence indicates that reprogramming of energy metabolism involving disturbances in energy production from a defect in cellular respiration with a shift to glycolysis is a core hallmark of cancer. Alterations in cancer cell energy metabolism are linked to abnormalities in mitochondrial function. Mitochondrial dysfunction of cancer cells includes increased glycolysis, decreased apoptosis, and resistance to radiotherapy. The study was designed for two main points: firstly, to investigate whether exogen… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

2
89
1
6

Year Published

2020
2020
2024
2024

Publication Types

Select...
6
2
1

Relationship

0
9

Authors

Journals

citations
Cited by 110 publications
(98 citation statements)
references
References 50 publications
2
89
1
6
Order By: Relevance
“…Beyond mitochondrial disease treatment, the transplantation of exogenous mitochondrial has been evaluated in the attempt to mitigate mitochondrial dysfunction of cancer cells. This approach has been shown to attenuate the Warburg effect and to enhance the sensitivity to anti-tumoral treatments (i.e., chemotherapy or radiotherapy) in breast cancer [ 188 ] or glioma cells [ 189 ].…”
Section: Current Therapeutic Approaches and Clinical Trials For Thmentioning
confidence: 99%
See 1 more Smart Citation
“…Beyond mitochondrial disease treatment, the transplantation of exogenous mitochondrial has been evaluated in the attempt to mitigate mitochondrial dysfunction of cancer cells. This approach has been shown to attenuate the Warburg effect and to enhance the sensitivity to anti-tumoral treatments (i.e., chemotherapy or radiotherapy) in breast cancer [ 188 ] or glioma cells [ 189 ].…”
Section: Current Therapeutic Approaches and Clinical Trials For Thmentioning
confidence: 99%
“…Overall, and similar to what is observed in the rescue of damaged cells following intercellular mitochondria transfer from MSCs, studies testing the therapeutic efficacy of mitochondria transplantation indicate that mitochondria need to be functional to exert their beneficial effects [ 178 , 182 , 188 ]. Strikingly, mitochondria used for therapeutic purposes may be of autologous, allogeneic, or xenogeneic origin, because, in all the cases, transplanted mitochondria have been reported to be non-immunogenic [ 178 , 185 , 186 , 187 , 188 , 189 , 190 ]. Although the mitochondrial transplantation procedure remains largely experimental, this technique has been successfully applied in the damaged hearts of five pediatric patients sharing ischemia-reperfusion-associated myocardial dysfunction [ 191 ].…”
Section: Current Therapeutic Approaches and Clinical Trials For Thmentioning
confidence: 99%
“…When the microvesicles enter the cells, the fusion of the vesicle membrane with the cytosol membrane would potentially make the intact mitochondria into the cytosol [33]. The entry mechanism of mitochondria into cells would be associated with actin-mediated endocytosis because actin polymerization inhibitors can prevent the internalization of mitochondria by cells [34,35]. After the mitochondria enter cells, they are transported to lysosomes, then majority of the mitochondria can escape from the lysosomes and play roles in cytosol [36].…”
Section: Discussionmentioning
confidence: 99%
“…No. C2006, Beyotime Biotechnology, Shanghai, China) based on a previously described method [41,42]. Single-cell suspensions of mNSCs and Neuro-2a cells were prepared and then coincubated with JC-1 working solution for 20 min at 37 ℃.…”
Section: Mitochondrial Membrane Potential (Mmp) Analysismentioning
confidence: 99%